tirzepatide pregnancy breastfeeding guidance and breastfeeding: New research offers hope for postpartum moms Returning to tirzepatide while breastfeeding?

After 12 months of treatment, people who took: Tirzepatide lost an average of 15% of their body weight Semaglutide lost an average of 8% of their body weight While the potential weight loss outcomes with both drugs are promising, these medications arent a cure-all

Pay close attention to what happens in your body and notice any side effects

While large-scale randomized clinical trials are still needed, the existing research makes a compelling case for adding copper peptides to a comprehensive hair care routine

When gut bacteria ferment fiber, they produce short-chain fatty acids (SCFAs) that directly signal intestinal cells to release GLP-1

Connecting copper and cancer: from transition metal signalling to metalloplasia

Body Composition Results (12mg Dose, 48 Weeks) Context on lean mass loss: Some lean mass loss (25-30%) is typical with any significant weight loss, including bariatric surgery Lean mass includes muscle, water, bone, and organs, not just muscle The glucagon component may help preserve muscle compared to GLP-1-only drugs Resistance training + adequate protein (1.0-1.2g/kg daily) can minimize muscle loss Visceral Fat Reduction Retatrutide also led to large reductions in visceral adipose tissue (VAT), the fat surrounding internal organs that's linked to metabolic disease